Description
Kamomis 100
Volume: 1 vial × 100 units
Active ingredient: Clostridium botulinum toxin type A (In-house) 100units
Stabilizer: Human serum albumin (In-house) 0.5 mg
Tonic adjuster: Sodium chloride (Korean Pharmacopoeia) 0.9 mg
Kamomis, manufactured by Maypharm, a South Korean company, contains 100 units of vacuum-dried type A Clostridium Botulinum toxin. Vacuum drying gives this product a higher purity, greater consistency, and enhanced stability compared to other botox treatments.
Additionally, Kamomis 100 is easier to handle, making injections more accurate and reducing waste. Also, this product is safe to use, as there is zero risk of an allergic reaction during use. What's more, Kamomis is ideal for treating severe wrinkles and glabellar lines in adults, resulting in a more youthful appearance.
Key Benefits of Kamomis
This product contains highly stable Clostridium botulinum, which ensures that the product remains potent over a longer period.
• It contains vacuum-dried Botulinum toxin, which guarantees a higher level of purity than freeze-dried ones.
• This cosmetic product is quite easy to handle and reconstitute, especially during preparation and administration.
• There is a minimal risk of an allergic reaction when using Kamomis, making it quite safe to use.
• It helps eliminate wrinkles, glabellar lines, and fine lines, making facial skin appear younger.
Is Kamomis for You?
• This injection is ideal for people looking to eliminate aging symptoms such as wrinkles, fine lines, and glabellar lines from their face.
• It is safe, making it ideal for use on all skin types regardless of sensitivity.
• Not sure you want to use Botox consistently? Kamomis is just the ideal solution for you, as it remains potent over time and is easy to handle.
Dosage and administration
Glabellar wrinkles
Dilute with preservative-free sterile 0.9% saline to 100 U/2.5 mL (4 U/0.1 mL).
Using 30-gauge needles, inject 0.1 mL into 2 points for each corrugator muscle and 1 point for the procerus muscle, for a total of 20 U in 5 points.
To reduce the incidence of complications of ptosis, avoid injecting near the levator palpebrae superioris muscle in patients with large brow depressors. When injecting into the medial corrugator and central brow, injection should be performed at least 1cm from the upper ciliary margin.
Be careful to avoid intravascular injection, and apply firm pressure to the supraorbital rim using the thumb or index finger to prevent inferior migration of the drug. The needle should point centrally and superiorly during the injection, and the exact dose must be injected.
The corrugator and orbicularis oculi muscles move the central forehead to create glabellar wrinkles.
The procerus and depressor supercell muscles pull the forehead inferiorly.
These muscles create frown lines or glabellar wrinkles. The location, size, and use of muscles vary between
individuals, and the effective dose is determined by overall observation of the movement of surface muscles by each patient.
The effect of this drug on glabellar wrinkles lasts for around 3 to 4 months. The safety and efficacy of this drug for frequent administration has not been clinically evaluated and is not recommended.
